Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
<p>Abstract</p> <p>Background</p> <p>Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD).</p> <p>Methods<...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | BMC Psychiatry |
Online Access: | http://www.biomedcentral.com/1471-244X/11/42 |